Results 1 to 10 of about 1,055,367 (200)

Private Data Manipulation in Sponsored Search Auctions

open access: yesCAAI Artificial Intelligence Research, 2023
The repeated nature of sponsored search auctions allows the seller to implement Myerson’s auction to maximize revenue using past data. But since these data are provided by strategic buyers in the auctions, they can be manipulated, which may hurt the ...
Xiaotie Deng, Tao Lin, Tao Xiao
doaj   +2 more sources

Medical specialty society-sponsored data registries: opportunities in plastic surgery. [PDF]

open access: yesPlast Reconstr Surg, 2013
Clinical data registries are commonly used worldwide and are implemented for a variety of purposes ranging from physician or facility clinic logs for tracking patients, to collecting outcomes data, to measuring quality improvement or safety of medical devices. In the United States, the U.S.
Hume KM   +4 more
europepmc   +4 more sources

Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability [PDF]

open access: yesBMC Medicine, 2018
Background Clinical trial transparency is important to participants, trialists, publishers, and regulators, and there have been recent major policy changes by the pharmaceutical industry regarding clinical study data sharing.
Ashley M. Hopkins   +2 more
doaj   +4 more sources

The Political Economy of Federally Sponsored Data

open access: yesJournal of eScience Librarianship, 2013
Librarian involvement in the Open Access (OA) movement has traditionally focused on access to scholarly publications. Recent actions by the White House have focused attention on access on the data produced from federally sponsored research.
Bart Ragon
doaj   +3 more sources

Data presentation in industry-sponsored cardiac device trials

open access: yesIndian Heart Journal
Industry's influence on clinical trials is well known and extends to various aspects beyond funding, including industry-affiliated authors and industry-affiliated analysts.
Baskaran Chandrasekar
doaj   +3 more sources

Availability of Clinical Trial Data From Industry‐Sponsored Cardiovascular Trials [PDF]

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundIndustry‐sponsored clinical trials produce high‐quality data sets that can be used by researchers to generate new knowledge. We assessed the availability of individual participant‐level data (IPD) from large cardiovascular trials conducted by ...
Karthik Murugiah   +4 more
doaj   +3 more sources

Sponsored Data with ISP Competition [PDF]

open access: yes2019 31st International Teletraffic Congress (ITC 31), 2019
We analyze the effect of sponsored data platforms when Internet service providers (ISPs) compete for subscribers and content providers (CPs) compete for a share of the bandwidth usage by the customers. Our analytical model is of a full information, leader-follower game. ISPs lead and set prices for sponsorship.
Vyavahare, Pooja   +2 more
openaire   +2 more sources

Offering zero-rated content in the shadow of net neutrality

open access: yesMarket and Competition Law Review, 2021
In the recent Telenor case, the EU Court of Justice has for the first time interpreted the relationship between net neutrality regulation and zero-rating offers, considering the former incompatible with the offer of packages in which data traffic ...
Giuseppe Colangelo, Valerio Torti
doaj   +1 more source

Application-Oriented Free Data in Cellular Networks

open access: yesIEEE Access, 2020
Over the past several years, sponsored mobile data and the payment directions on the Internet have been two major subjects in network economics. Several tier-1 service providers (SPs) created their frameworks for sponsored mobile data by cooperating with
Behdad Heidarpour   +4 more
doaj   +1 more source

An In Vitro Assessment of Immunostimulatory Responses to Ten Model Innate Immune Response Modulating Impurities (IIRMIs) and Peptide Drug Product, Teriparatide

open access: yesMolecules, 2021
Understanding, predicting, and minimizing the immunogenicity of peptide-based therapeutics are of paramount importance for ensuring the safety and efficacy of these products. The so-called anti-drug antibodies (ADA) may have various clinical consequences,
Claire K. Holley   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy